Research

LIke ThisLIke ThisLIke This

Christina  Ullrich, MD, MPH

Christina Ullrich, MD, MPH
Research Center:
Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
Department:
Medicine Research
Division
Hematology/Oncology Research
Hospital Title:
Instructor in Medicine
Academic Title:
Clinical Instructor, Harvard Medical School
Research Focus Area:
Hematology/Oncology
Contact:
617-632-4997
Contact Via Email
Send an email to SendYour Name*Your Email Address*Subject*Comments*

Research Overview

 Dr. Ullrich’s research interests include symptom management in children with life-threatening illness, with a particular focus on fatigue in children with cancer. She seeks to better understand fatigue in children with serious illness, with the ultimate aim of designing interventions to reduce suffering from this symptom. She is currently conducting a trial evaluating a pharmacologic intervention for children with cancer-related fatigue. As a member of the Hematopoietic Stem Cell Transplant (HSCT) Program, at Dana-Farber and Children’s Hospital Boston, Dr. Ullrich is also interested in integration of palliative care with HSCT to optimize comfort, communication, and quality of life for children undergoing HSCT. 

About Christina 

Ullrich Dr. Ullrich received her MD from Harvard Medical School and her MPH from the Harvard School of Public Health. She completed her residency through the Boston Combined Residency Program (Children’s Hospital Boston and Boston Medical Center). Dr. Ullrich has completed fellowships in both pediatric hematology/oncology and pediatric palliative care at Dana-Farber Cancer Institute and Children’s Hospital Boston. She is board certified in pediatrics, pediatric hematology/oncology and hospice and palliative medicine. 

Dr. Ullrich received a Young Investigator Award from the American Academy of Hospice and Palliative Medicine for her work investigating cancer-related fatigue in children. Her work aiming to better understand and improve symptom distress and quality of life in children who undergo HSCT is currently funded by a K23 Career Development Award from the National Institutes of Health.

Publications

Publications powered by Harvard Catalyst Profiles
  1. Rosenberg AR, Orellana L, Ullrich C, Kang T, Geyer JR, Feudtner C, Dussel V, Wolfe J. Quality of Life in Children With Advanced Cancer: A Report From the PediQUEST Study. J Pain Symptom Manage. 2016 Aug; 52(2):243-53.
  2. Ullrich CK, Lehmann L, London WB, Guo D, Sridharan M, Koch R, Wolfe J. End-of-Life Care Patterns Associated with Pediatric Palliative Care among Children Who Underwent Hematopoietic Stem Cell Transplant. Biol Blood Marrow Transplant. 2016 Jun; 22(6):1049-55.
  3. Mullin J, Ullrich C. Caring for Children Who Have Severe Neurological Impairment. J Palliat Med. 2015 Nov; 18(11):991.
  4. Ullrich CK, Rodday AM, Bingen K, Kupst MJ, Patel SK, Syrjala KL, Harris LL, Recklitis CJ, Schwartz L, Davies S, Guinan EC, Chang G, Wolfe J, Parsons SK. Parent Outlook: How Parents View the Road Ahead as They Embark on Hematopoietic Stem Cell Transplantation for Their Child. Biol Blood Marrow Transplant. 2016 Jan; 22(1):104-11.
  5. Wolfe J, Orellana L, Ullrich C, Cook EF, Kang TI, Rosenberg A, Geyer R, Feudtner C, Dussel V. Symptoms and Distress in Children With Advanced Cancer: Prospective Patient-Reported Outcomes From the PediQUEST Study. J Clin Oncol. 2015 Jun 10; 33(17):1928-35.
  6. Ullrich CK, Wolfe J. Caring for children living with life-threatening illness: a growing relationship between pediatric hospital medicine and pediatric palliative care. Pediatr Clin North Am. 2014 Aug; 61(4):xxi-xxiii.
  7. Bogetz JF, Ullrich CK, Berry JG. Pediatric hospital care for children with life-threatening illness and the role of palliative care. Pediatr Clin North Am. 2014 Aug; 61(4):719-33.
  8. Wolfe J, Orellana L, Cook EF, Ullrich C, Kang T, Geyer JR, Feudtner C, Weeks JC, Dussel V. Improving the care of children with advanced cancer by using an electronic patient-reported feedback intervention: results from the PediQUEST randomized controlled trial. J Clin Oncol. 2014 Apr 10; 32(11):1119-26.
  9. Ullrich C, Morrison RS. Pediatric palliative care research comes of age: what we stand to learn from children with life-threatening illness. J Palliat Med. 2013 Apr; 16(4):334-6.
  10. Wolfe J, Dussel V, Neville B, Cook E, Chen K, Kang T, Geyer R, Ullrich C, Feudtner C, Weeks J. Longitudinal Assessment of Symptom Distress in Children with Advanced Cancer: Report of the First 20 Weeks in the Pediatric Quality-of-Life Evaluation of Symptoms Technology (PediQUEST) Study (311-A). J Pain Symptom Manage. 2011 Jan; 41(1):187.
  11. Show all
  12. Dussel V, Neville B, Chen K, Cook E, Geyer R, Kang T, Ullrich C, Feudtner C, Weeks J, Wolfe J. Routine Feedback of Patient-Reported Distress in Children With Advanced Cancer: Provider and Family Satisfaction With the Pediatric Quality of Life and Evaluation of Symptoms Technology (PediQUEST) System (311-B). J Pain Symptom Manage. 2011 Jan; 41(1):187-8.
  13. Ullrich CK, Dussel V, Hilden JM, Sheaffer JW, Moore CL, Berde CB, Wolfe J. Fatigue in children with cancer at the end of life. J Pain Symptom Manage. 2010 Oct; 40(4):483-94.
  14. Ullrich CK, Dussel V, Hilden JM, Sheaffer JW, Lehmann L, Wolfe J. End-of-life experience of children undergoing stem cell transplantation for malignancy: parent and provider perspectives and patterns of care. Blood. 2010 May 13; 115(19):3879-85.
  15. Shaker M, Jenkins P, Ullrich C, Brugnara C, Nghiem BT, Bernstein H. An economic analysis of anemia prevention during infancy. J Pediatr. 2009 Jan; 154(1):44-9.
  16. Shaker M, Jenkins P, Ullrich C, et al. An Economic Analysis of Anemia Prevention during Infancy. J. Peds. 2008; in press.
  17. Joanne Wolfe and Christina Ullrich. Pain and Symptom Control in Pediatrics. Palliative Medicine (Walsh, Caraceni, Fainsinger, Foley, Glare, Goh, Lloyd-Williams, Radbruch). 2008.
  18. Ullrich CK, Mayer OH. Assessment and management of fatigue and dyspnea in pediatric palliative care. Pediatr Clin North Am. 2007 Oct; 54(5):735-56, xi.
  19. Henry Bernstein, DO; Sarah Isbey; Christina Ullrich, MD; Marcus Shaker, MD. An Economic Analysis of Anemia Prevention During Infancy. Pediatric Research. 2007.
  20. John Graef, Joanne Wolfe, and Christina Ullrich. Manual of Pediatric Therapeutics (Graef, Wolfsdorf, Greenes). 2007; 1-16.
  21. Ullrich C and Wu A. American Academy of Pediatrics Pedialink Hot Topics Educational Module: Iron Deficiency. 2007.
  22. CK Ullrich, JM Hilden, JW Sheaffer, CL Moore, CB Berde, JC Weeks, J Wolfe. Factors associated with fatigue in children with cancer at the end of life. Journal of Clinical Oncology. 2006; 24(18S):486S.
  23. Ullrich C, Brugnara C, Bernstein H. . Approaches to screening for iron deficiency in pediatrics: An update article. Italian J. Pediatrics. 2006; 32(5).
  24. Wright K, Ullrich C, Scott A, Brugnara C, Bernstein H. Diagnosis of Iron Deficiency in Children. 2006.
  25. Wright K, Ullrich C, Scott A, Brugnara C, Bernstein H. Iron Deficiency in Infants and Toddlers. 2006.
  26. Ullrich C, Wu A, Armsby C, Rieber S, Wingerter S, Brugnara C, Shapiro D, Bernstein H. Screening healthy infants for iron deficiency using reticulocyte hemoglobin content. JAMA. 2005 Aug 24; 294(8):924-30.
  27. Tenney-Soeiro R, Ullrich C. The importance of newborn screening in resident education. Pediatr Ann. 2003 Aug; 32(8):549-50.
  28. Wingerter SL, Ullrich CK, Rieber S, Brugnara C, Bernstein HH. Diet history as an adjunct to hemoglobin (Hb) and reticulocyte hemoglobin content (CHr) in screening for iron deficiency. Pediatric Research. 2003; 53(4):293A.
  29. Ullrich CK, Wingerter SL, Rieber S, Brugnara C, Bernstein HH. Reticulocyte hemoglobin content (CHr) is better than hemoglobin in identifying iron deficiency. Pediatric Research. 2003; 53(4):293A.
  30. Park IW, Ullrich CK, Schoenberger E, Ganju RK, Groopman JE. HIV-1 Tat induces microvascular endothelial apoptosis through caspase activation. J Immunol. 2001 Sep 1; 167(5):2766-71.
  31. Ullrich CK, Groopman JE, Ganju RK. HIV-1 gp120- and gp160-induced apoptosis in cultured endothelial cells is mediated by caspases. Blood. 2000 Aug 15; 96(4):1438-42.
  32. Mitchelhill KI, Michell BJ, House CM, Stapleton D, Dyck J, Gamble J, Ullrich C, Witters LA, Kemp BE. Posttranslational modifications of the 5'-AMP-activated protein kinase beta1 subunit. J Biol Chem. 1997 Sep 26; 272(39):24475-9.
  33. Ullrich CK, Widmer J, Park JP, Mohandas TK, Witters LA. Assignment of acetyl-CoA carboxylase-beta (ACACB) to human chromosome band 12q24.1 by in situ hybridization. Cytogenet Cell Genet. 1997; 77(3-4):176-7.
  34. Christina K. Ullrich. Acifluorfen Resistance in Arabidopsis thaliana. 1994.
  35. Dussel V, Orellana L, Soto N, Chen K, Ullrich C, Kang TI, Geyer JR, Feudtner C, Wolfe J. Feasibility of Conducting a Palliative Care Randomized Controlled Trial in Children With Advanced Cancer: Assessment of the PediQUEST Study. J Pain Symptom Manage. 2015 Jun; 49(6):1059-69.
LIke ThisLIke ThisLIke This

RELATED RESEARCH CENTER

Dana-Farber/Boston Children’s Cancer and Blood Disorders Center

Dana-Farber/Boston Children's Cancer and Blood Disorders Center is one of the top research centers in the world for pediatric cancers and blood diseases. It brings together laboratory scientists and clinical researchers from Dana-Farber Cancer Institute and Boston Children’s Hospital in a single program. We investigate pediatric cancers and non-malignant blood disorders from every angle—from examining cells under the microscope to tracking the effectiveness of current drug regimens using the most advanced molecular methods—so that we can create better treatments for children seen here and around the world.

Learn more
Close